Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Olanzapine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zalasta 2.5mg tablets
040201060BCAAAD
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 20mg orodispersible tablets
040201060BCAJAV
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 20mg tablets
040201060BCAFAQ
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 5mg orodispersible tablets
040201060BCAGAS
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 7.5mg tablets
040201060BCACAB
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zyprexa 10mg powder for solution for injection vials
040201060BBAIAN
|
Zyprexa | Olanzapine | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.